Scott B. Ullem, CVP, Chief Financial Officer at Edwards Lifesciences Corp (EW), sold 10,850 shares at $87.47 ($949K) on 2024-06-20, disclosed to the SEC on 2024-06-20.
Scheduled sale ($949k) by CVP, Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $87.47 | 5,225 | $457K | 48.1% |
| 2 | $87.47 | 5,225 | $457K | 48.1% |
| 3 | $88.11 | 400 | $35K | 3.7% |
| Total | $87.49 avg | 10,850 | $949K | 100% |
| Filing → |
| EW | SELL | 2025-12-09 | $650K | — | Filing → |
| EW | SELL | 2025-11-10 | $2.2M | — | Filing → |
| EW | SELL | 2025-05-09 | $1.7M | — | Filing → |